Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1"
From the failure of gut extracts in diabetic patients' therapy to the effective action in cardiovascular outcomes [...].
Gespeichert in:
| Veröffentlicht in: | International journal of molecular sciences 2024-02, Vol.25 (4), p.1997 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 4 |
| container_start_page | 1997 |
| container_title | International journal of molecular sciences |
| container_volume | 25 |
| creator | Puddu, Alessandra Maggi, Davide |
| description | From the failure of gut extracts in diabetic patients' therapy to the effective action in cardiovascular outcomes [...]. |
| doi_str_mv | 10.3390/ijms25041997 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2932015466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A784040267</galeid><sourcerecordid>A784040267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c381t-32d106f31fe33ac589b803588fe990451ff5cce225122ca1facdc33de52b47cb3</originalsourceid><addsrcrecordid>eNptkc1Lw0AQxRdRbP24eZZQLx6M7u5kk6y3UmotCArqOWw3s2Vrkq3Z5ND_3gSrVpE5zDD83vCGR8gZo9cAkt7YVem5oBGTMtkjQxZxHlIaJ_s784Aceb-ilAMX8pAMIAUZx4kYkunzGrVVRTD3vsXbYDSuGhvayhSqLFXj6k0wNQZ14wNnglnRarV0VVjYNwyecN3YHEM2OiEHRhUeT7f9mLzeTV8m9-HD42w-GT-EGlLWhMBzRmMDzCCA0iKVi5SCSFODUtJIMGOE1si5YJxrxYzSuQbIUfBFlOgFHJPLz7vr2r236JustF5jUagKXeszLoFTJqI47tCLP-jKtXXVuespKpM4guSHWqoCs-5t19RK90ezcZJGNKI87qnrf6iuciytdhUa2-1_Ca4-Bbp23tdosnVtS1VvMkazPrVsN7UOP996bRcl5t_wV0zwAbJNjvo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2930976437</pqid></control><display><type>article</type><title>Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1"</title><source>MEDLINE</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Puddu, Alessandra ; Maggi, Davide</creator><creatorcontrib>Puddu, Alessandra ; Maggi, Davide</creatorcontrib><description>From the failure of gut extracts in diabetic patients' therapy to the effective action in cardiovascular outcomes [...].</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms25041997</identifier><identifier>PMID: 38396675</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Anti-Inflammatory Agents - pharmacology ; Anti-Inflammatory Agents - therapeutic use ; Anti-inflammatory drugs ; Cardiovascular System ; Diabetes ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetics ; Disease ; Exenatide ; Glucagon ; Glucagon-Like Peptide 1 - pharmacology ; Glucagon-Like Peptide 1 - therapeutic use ; Glucagon-Like Peptide-1 Receptor ; Glucose ; Heart ; Humans ; Hyperglycemia ; Hypoglycemic Agents - pharmacology ; Inflammation ; Neurodegeneration ; Overweight ; Oxidative stress ; Peptides ; Physiology ; Type 2 diabetes ; Weight control</subject><ispartof>International journal of molecular sciences, 2024-02, Vol.25 (4), p.1997</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c381t-32d106f31fe33ac589b803588fe990451ff5cce225122ca1facdc33de52b47cb3</cites><orcidid>0000-0002-9084-2636 ; 0000-0003-3928-1295</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38396675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Puddu, Alessandra</creatorcontrib><creatorcontrib>Maggi, Davide</creatorcontrib><title>Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1"</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>From the failure of gut extracts in diabetic patients' therapy to the effective action in cardiovascular outcomes [...].</description><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Anti-inflammatory drugs</subject><subject>Cardiovascular System</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetics</subject><subject>Disease</subject><subject>Exenatide</subject><subject>Glucagon</subject><subject>Glucagon-Like Peptide 1 - pharmacology</subject><subject>Glucagon-Like Peptide 1 - therapeutic use</subject><subject>Glucagon-Like Peptide-1 Receptor</subject><subject>Glucose</subject><subject>Heart</subject><subject>Humans</subject><subject>Hyperglycemia</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Inflammation</subject><subject>Neurodegeneration</subject><subject>Overweight</subject><subject>Oxidative stress</subject><subject>Peptides</subject><subject>Physiology</subject><subject>Type 2 diabetes</subject><subject>Weight control</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkc1Lw0AQxRdRbP24eZZQLx6M7u5kk6y3UmotCArqOWw3s2Vrkq3Z5ND_3gSrVpE5zDD83vCGR8gZo9cAkt7YVem5oBGTMtkjQxZxHlIaJ_s784Aceb-ilAMX8pAMIAUZx4kYkunzGrVVRTD3vsXbYDSuGhvayhSqLFXj6k0wNQZ14wNnglnRarV0VVjYNwyecN3YHEM2OiEHRhUeT7f9mLzeTV8m9-HD42w-GT-EGlLWhMBzRmMDzCCA0iKVi5SCSFODUtJIMGOE1si5YJxrxYzSuQbIUfBFlOgFHJPLz7vr2r236JustF5jUagKXeszLoFTJqI47tCLP-jKtXXVuespKpM4guSHWqoCs-5t19RK90ezcZJGNKI87qnrf6iuciytdhUa2-1_Ca4-Bbp23tdosnVtS1VvMkazPrVsN7UOP996bRcl5t_wV0zwAbJNjvo</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Puddu, Alessandra</creator><creator>Maggi, Davide</creator><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9084-2636</orcidid><orcidid>https://orcid.org/0000-0003-3928-1295</orcidid></search><sort><creationdate>20240201</creationdate><title>Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1"</title><author>Puddu, Alessandra ; Maggi, Davide</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c381t-32d106f31fe33ac589b803588fe990451ff5cce225122ca1facdc33de52b47cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Anti-inflammatory drugs</topic><topic>Cardiovascular System</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetics</topic><topic>Disease</topic><topic>Exenatide</topic><topic>Glucagon</topic><topic>Glucagon-Like Peptide 1 - pharmacology</topic><topic>Glucagon-Like Peptide 1 - therapeutic use</topic><topic>Glucagon-Like Peptide-1 Receptor</topic><topic>Glucose</topic><topic>Heart</topic><topic>Humans</topic><topic>Hyperglycemia</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Inflammation</topic><topic>Neurodegeneration</topic><topic>Overweight</topic><topic>Oxidative stress</topic><topic>Peptides</topic><topic>Physiology</topic><topic>Type 2 diabetes</topic><topic>Weight control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Puddu, Alessandra</creatorcontrib><creatorcontrib>Maggi, Davide</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Puddu, Alessandra</au><au>Maggi, Davide</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1"</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>25</volume><issue>4</issue><spage>1997</spage><pages>1997-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>From the failure of gut extracts in diabetic patients' therapy to the effective action in cardiovascular outcomes [...].</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>38396675</pmid><doi>10.3390/ijms25041997</doi><orcidid>https://orcid.org/0000-0002-9084-2636</orcidid><orcidid>https://orcid.org/0000-0003-3928-1295</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1422-0067 |
| ispartof | International journal of molecular sciences, 2024-02, Vol.25 (4), p.1997 |
| issn | 1422-0067 1661-6596 1422-0067 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2932015466 |
| source | MEDLINE; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Anti-Inflammatory Agents - pharmacology Anti-Inflammatory Agents - therapeutic use Anti-inflammatory drugs Cardiovascular System Diabetes Diabetes Mellitus, Type 2 - drug therapy Diabetics Disease Exenatide Glucagon Glucagon-Like Peptide 1 - pharmacology Glucagon-Like Peptide 1 - therapeutic use Glucagon-Like Peptide-1 Receptor Glucose Heart Humans Hyperglycemia Hypoglycemic Agents - pharmacology Inflammation Neurodegeneration Overweight Oxidative stress Peptides Physiology Type 2 diabetes Weight control |
| title | Special Issue: "Anti-inflammatory Effects of Glucagon-like Peptide-1" |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A10%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Special%20Issue:%20%22Anti-inflammatory%20Effects%20of%20Glucagon-like%20Peptide-1%22&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Puddu,%20Alessandra&rft.date=2024-02-01&rft.volume=25&rft.issue=4&rft.spage=1997&rft.pages=1997-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms25041997&rft_dat=%3Cgale_proqu%3EA784040267%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2930976437&rft_id=info:pmid/38396675&rft_galeid=A784040267&rfr_iscdi=true |